Guardion Health Sciences, Inc. (GHSI) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 26 transactions totaling $2.5M, demonstrating a bearish sentiment with -$781.7K in net insider flow. The most recent transaction on Aug 26, 2024 involved a sale of 8,250 shares valued at $130.1K.
No significant insider buying has been recorded for GHSI in the recent period.
No significant insider selling has been recorded for GHSI in the recent period.
Based on recent SEC filings, insider sentiment for GHSI is bearish with an Insider Alignment Score of 34/100 and a net flow of -$781.7K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Guardion Health Sciences, Inc. (GHSI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading GHSI stock, having executed 26 transactions in the past 90 days. The most active insider is Family Foundation Radoff (Executive), who has made 8 transactions totaling $2.5M.
Get notified when executives and directors at GHSI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Foundation Radoff Family | Executive | Sale | 8,250 | $15.77 | $130.1K | |
| Aug 26, 2024 | Foundation Radoff Family | Executive | Sale | 10,054 | $13.80 | $138.7K | |
| Aug 26, 2024 | Foundation Radoff Family | Executive | Sale | 52,686 | $13.54 | $713.4K | Large |
| Aug 26, 2024 | Foundation Radoff Family | Executive | Sale | 44,550 | $14.46 | $644.2K | Large |
| Jan 10, 2023 | Foundation Radoff Family | Executive | Purchase | 18,630 | $7.31 | $136.2K | |
| Jan 10, 2023 | Foundation Radoff Family | Executive | Purchase | 13,270 | $8.00 | $106.2K | |
| Jan 9, 2023 | Foundation Radoff Family | Executive | Purchase | 63,983 | $6.78 | $433.8K | |
| Jan 9, 2023 | Foundation Radoff Family | Executive | Purchase | 20,838 | $7.19 | $149.8K | |
| Jan 6, 2022 | Scholtes Bret | Executive | Payment | 37,175 | $0.65 | $24.2K | |
| Aug 31, 2021 | Scholtes Bret | Executive | Purchase | 5,500 | $1.23 | $6.8K | |
| Aug 30, 2021 | A. Gagliano Donald | Executive | Purchase | 5,000 | $1.25 | $6.3K | |
| Aug 30, 2021 | Scholtes Bret | Executive | Purchase | 4,500 | $1.26 | $5.7K | |
| Aug 20, 2021 | N. Weingarten Robert | Executive | Award | 10,000 | $1.14 | $11.4K | |
| Jan 6, 2021 | Scholtes Bret | Executive | Award | 152,671 | $N/A | $0 | |
| Jan 6, 2021 | Scholtes Bret | Executive | Award | 916,023 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 4 | $1.6M | 63.3% |
Purchase(P) | 7 | $844.7K | 32.9% |
Award(A) | 14 | $73.7K | 2.9% |
Payment(F) | 1 | $24.2K | 0.9% |
Insider selling pressure at Guardion Health Sciences, Inc. has increased, with 7 insiders executing 26 transactions across all time. Total sales of $1.6M significantly outpace purchases of $844.7K, resulting in a net outflow of $781.7K. This selling activity appears largely discretionary, which may warrant closer attention from investors.